Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer von Lippman, Scott M., Lee, J. Jack, Karp, Daniel D., Vokes, Everett E., Benner, Steven E., Goodman, Gary E., Khuri, Fadlo R., Marks, Randolph, Winn, Rodger J., Fry, Willard, Graziano, Stephen L., Gandara, David R., Okawara, Gordon, Woodhouse, Charles L., Williams, Brendell, Perez, Cherie, Kim, Hyung W., Lotan, Reuben, Roth, Jack A., Hong, Waun Ki

Volltext

Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer von GRAZIANO, S. L, GAMBLE, G. P, NEWMAN, N. B, ABBOTT, L. Z, ROONEY, M, MOOKHERJEE, S, LAMB, M. L, KOHMAN, L. J, POIESZ, B. J

Volltext

Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer von CHOY, H, SAFRAN, H, AKERLEY, W, GRAZIANO, S. L, BOGART, J. A, COLE, B. F

Volltext

A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC) von Stinchcombe, T.E., Janne, P.A., Wang, X., Bertino, E.M., Weiss, J.M., Bazhenova, L., Gu, L., Lau, C.J., Paweletz, C.P., Jaslowski, A.J., Gerstner, G.J., Baggstrom, M.Q., Graziano, S.L., Bearden, J., Vokes, E.E.

Volltext

Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer von GRAZIANO, S. L, TATUM, A. H, GONCHOROFF, N. J, NEWMAN, N. B, KOHMAN, L. J

Volltext

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer von Graziano, S L, Mazid, R, Newman, N, Tatum, A, Oler, A, Mortimer, J A, Gullo, J J, DiFino, S M, Scalzo, A J

Volltext

PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci from the Arctic cisco (Coregonus autumnalis) von RAMEY, A., GRAZIANO, S. L., NIELSEN, J. L.

Volltext

Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer von Mehdi, Syed A, Etzell, Joan E, Newman, Nancy B, Weidner, Noel, Kohman, Leslie J, Graziano, Stephen L

Volltext

Cryptic Mucor infection leading to massive cerebral infarction at initiation of antileukemic chemotherapy von MATHUR, S. C, FRIEDMAN, H. D, KENDE, A. I, DAVIS, R. L, GRAZIANO, S. L

Volltext

Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B von Blackstock, A. William, Herndon, James E., Paskett, Electra D., Perry, Michael C., Graziano, Stephen L., Muscato, Joseph J., Kosty, Michael P., Akerley, Wallace L., Holland, Jimmie, Fleishman, Stewart, Green, Mark R.

Volltext

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: A Cancer and Leukemia Group B study von Graziano, Stephen L., Kern, Jeffrey A., Herndon, James E., Tatum, Arthur, Brisson, Marie L, Memoli, Vincent, Sugarbaker, David, Skarin, Arthur T., Kreisman, Harvey, Green, Mark R.

Volltext

Chromosome alterations in human small cell lung cancer : frequent involvement of 5q von MIURA, I, GRAZIANO, S. L, JIN QUAN CHENG, DOYLE, L. A, TESTA, J. R

Volltext

Non-small cell lung cancer: clinical value of new biological predictors von Graziano, Stephen L.

Volltext

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer von Muss, Hyman B, Berry, Donald A, Cirrincione, Constance T, Theodoulou, Maria, Mauer, Ann M, Kornblith, Alice B, Partridge, Ann H, Dressler, Lynn G, Cohen, Harvey J, Becker, Heather P, Kartcheske, Patricia A, Wheeler, Judith D, Perez, Edith A, Wolff, Antonio C, Gralow, Julie R, Burstein, Harold J, Mahmood, Ahmad A, Magrinat, Gustav, Parker, Barbara A, Hart, Ronald D, Grenier, Debjani, Norton, Larry, Hudis, Clifford A, Winer, Eric P

Volltext

Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study von Graziano, Stephen L, Tatum, Arthur, Herndon, James E, Box, James, Memoli, Vincent, Green, Mark R, Kern, Jeffrey A

Volltext

Preoperative evaluation of stage I and stage II non-small cell lung cancer von Hatter, Jeffrey, Kohman, Leslie J., Mosca, Ralph S., Graziano, Stephen L., Veit, Linda J., Coleman, Mary

Volltext

1444PA randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC) von Stinchcombe, T E, Janne, P A, Wang, X, Bertino, E M, Weiss, J M, Bazhenova, L, Gu, L, Lau, C J, Paweletz, C P, Jaslowski, A J, Gerstner, G J, Baggstrom, M Q, Graziano, S L, Bearden, J, Vokes, E E

Volltext

1583PSMARCA4 deficient non-small cell lung cancer (NSCLC): A comprehensive genomic profiling (CGP) study von Graziano, S L, Lin, D, Elvin, J A, Vergilio, J-A, Killian, J K, Ngo, N, Ramkissoon, S, Severson, E, Hemmerich, A, Duncan, D, Edgerly, C, Ali, S M, Schrock, A B, Chung, J, Sokol, E S, Reddy, P, McGregor, K, Miller, V A, Alexander, B M, Ross, J S

Volltext

1549PNTRK1-3 genomic fusions in non-small cell lung cancer (NSCLC) determined by comprehensive genomic profiling von Ou, S-H I, Sokol, E S, Trabucco, S E, Jin, D X, Frampton, G M, Graziano, S L, Elvin, J A, Vergilio, J-A, Killian, J K, Ngo, N, Lin, D, Ramkissoon, S, Severson, E, Ali, S M, Schrock, A B, Chung, J, Reddy, P, McGregor, K, Alexander, B M, Ross, J S

Volltext

The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer von GRAZIANO, S. L, TATUM, A. H, NEWMAN, N. B, OLER, A, KOHMAN, L. J, VEIT, L. J, GAMBLE, G. P, COLEMAN, M. J, BARMADA, S, O'LEAR, S

Volltext